Protection against Helicobacter pylori Infection in BALB/c Mice by Oral or Intramuscular Administration of Multicomponent Vaccine of rCagA +LPS +CpG

References (34)

1. 1 Molecular Cloning: A Laboratory Manual
2. 2 Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays [DOI]
3. 3 Rapid colorimetric assay for cell growth and survival [DOI]
4. 4 Immunization of Mice with Urease Vaccine Affords Protection against Helicobacter pylori Infection in the Absence of Antibodies and Is Mediated by MHC Class II–restricted Responses [DOI]
5. 5 Helicobacter pylori Modulates the T Helper Cell 1/T Helper Cell 2 Balance through Phase-variable Interaction between Lipopolysaccharide and DC-SIGN [DOI]
6. 6 Helicobacter pylori -Induced Th17 Responses Modulate Th1 Cell Responses, Benefit Bacterial Growth, and Contribute to Pathology in Mice [DOI]
7. 7 The CD4+ T Cell-Mediated IFN-γ Response to Helicobacter Infection Is Essential for Clearance and Determines Gastric Cancer Risk [DOI]
8. 8 Protection Against Helicobacter pylori Infection Following Immunization Is IL-12-Dependent and Mediated by Th1 Cells [DOI]
9. 9 Safety and Immunogenicity of an Intramuscular Helicobacter pylori Vaccine in Noninfected Volunteers: A Phase I Study [DOI]
10. 10 Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers [DOI]
11. 11 Systemic immunization with urease protects mice against Helicobacter pylori infection [DOI]
12. 12 Oral immunization with HpaA affords therapeutic protective immunity against H. pylori that is reflected by specific mucosal immune responses [DOI]
13. 13 Proinflammatory Cytokine Gene Expression in the Stomach Correlates with Vaccine-Induced Protection against Helicobacter pylori Infection in Mice: an Important Role for Interleukin-17 during the Effector Phase [DOI]
14. 14 Systemic immunization with an epitope-based vaccine elicits a Th1-biased response and provides protection against Helicobacter pylori in mice [DOI]
15. 15 The Helicobacter pylori's protein VacA has direct effects on the regulation of cell cycle and apoptosis in gastric epithelial cells [DOI]
16. 16 Chimeric flagellin as the self-adjuvanting antigen for the activation of immune response against Helicobacter pylori [DOI]
17. 17 Inflammation, Immunity, and Vaccines for H elicobacter pylori Infection [DOI]
18. 18 Helicobacter pylori lipopolysaccharide promotes a Th1 type immune response in immunized mice [DOI]
19. 19 Immunization with Recombinant Helicobacter pylori Urease in Specific-Pathogen-Free Rhesus Monkeys ( Macaca mulatta ) [DOI]
20. 20 Clearance of Helicobacter pylori infection through immunization: the site of T cell activation contributes to vaccine efficacy [DOI]
21. 21 Sterilizing immunity against experimental Helicobacter pylori infection is challenge-strain dependent [DOI]
22. 22 Immune responses in mice to intranasal and intracutaneous administration of a DNA vaccine encoding Helicobacter pylori-catalase [DOI]
23. 23 vaccine development: Facing the challenge [DOI]
24. 24 Systemic Th1 Immunization of Mice againstHelicobacter pyloriInfection with CpG Oligodeoxynucleotides as Adjuvants Does Not Protect from Infection but Enhances Gastritis [DOI]
25. 25 Vaccination of mice with live recombinant Salmonella typhimurium aroA against H. pylori: parameters associated with prophylactic and therapeutic vaccine efficacy [DOI]
26. 26 Helicobacter pylori vaccine development: Optimisation of strategies and importance of challenging strain and animal model [DOI]
27. 27 Vaccination as a Method of Preventing Helicobacter pylori–Associated Gastric Cancer [DOI]
28. 28 Possible Correlates of Long-Term Protection againstHelicobacter pylorifollowing Systemic or Combinations of Mucosal and Systemic Immunizations [DOI]
29. 29 Development and Evaluation of a DNA Vaccine Based on Helicobacter pylori urease B: Failure to Prevent Experimental Infection in the Mouse Model [DOI]
30. 30 A recombinant fragment of Helicobacter pylori CagA affects proliferation of human cells.
31. 31 Vacunas en desarrollo: Helicobacter pylori [DOI]
32. 32 [Construction, expression and antigenic study of bivalent vaccine candidate with 26,000 OMP and heat short protein A of human Helicobacter pylori].
33. 33 [The role of Th1-type response and gamma-interferon in the protection induced by Helicobacter pylori vaccine].
34. 34 [Construction, expression and purification of UreB-Omp11 fusion protein of Helicobacter pylori and its immunocompetence].

Cited by 7

Showing 5 of 7 known citations — external sources report more than can currently be individually listed.

Related research

• No Association between Helicobacter Pylori Infection and Type 2 Diabetes Mellitus; A Case-control Study in the North-Western Part of Ghana — shares topic coverage
• Burden of Helicobacter pylori Infections and Associated Risk Factors among Cases of Iron Deficiency Anaemia in Egypt — shares topic coverage
• Impact of Dietary Behavior, Lifestyle & Socioeconomic Status on Patients Infected with H. pylori — shares topic coverage
• Anti-urease Activity of Mimusops elengi Linn (Sapotaceae) — shares topic coverage
• Association of H. pylori with Serum Iron Levels and Some Risk Factors in Children Aged 1-12 Years Attending the Buea Regional Hospital — shares topic coverage